Protein levels of EZH2 increase incrementally from benign nevi to cutaneous malignant melanoma, which also suggests that EZH2 may play a role in the pathogenesis and tumorigenesis of melanoma [98–100] (Fig. 4). The gene discussed is EZH2; the disease is melanoma.